GlassScriptPhysician profile
Matthew J Marano
NPI 1639112097
$39,190.75
in general payments reported to CMS, 2019-2025
30 companies · $3,125 in 2025
The $3,125 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,459 · 2020: $5,187 · 2021: $6,775 · 2022: $8,823 · 2023: $4,717 · 2024: $2,105 · 2025: $3,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,697 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,697.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,965.34 | 2019-2022 | |
| Abbvie INC. | $6,597.52 | 2022-2025 | |
| Sight Sciences, INC. | $5,230.30 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $3,255.85 | 2019-2025 | Clareon, Tryptyr, Acrysof Iq Panoptix Uv Iol |
| Bausch & Lomb Americas INC. | $1,805.57 | 2022-2025 | Xiidra, Envista Mx60 Iol, Miebo |
| Glaukos Corporation | $986.52 | 2020-2025 | Idose, Kxl System (Not Refurbished), Photrexa |
| Sun Pharmaceutical Industries INC. | $592.67 | 2019-2025 | Cequa |
| Horizon Therapeutics Plc | $460.58 | 2022-2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $427.15 | 2019-2023 | Catalys System, Tecnis Iol, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $419.14 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $393.83 | 2019-2021 | |
| Ocular Therapeutix, INC. | $268.09 | 2020-2025 | Dextenza |
| Oyster Point Pharma, INC. | $226.33 | 2022-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $221.15 | 2024-2025 | Vevye, Triesence |
| Biotissue Holdings INC. | $203.92 | 2020-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $178.47 | 2025 | Acthar |
| Rxsight INC | $147.03 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Iridex Corporation | $132.98 | 2022 | |
| Amgen INC. | $118.39 | 2024 | Tepezza |
| Aerie Pharmaceuticals, INC. | $114.29 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $107.27 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $94.36 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $66.72 | 2019 | |
| Omeros Corporation | $37.66 | 2021 | |
| Eyevance Pharmaceuticals LLC | $32.00 | 2022-2023 | Flarex |
| Shire North American Group INC | $29.55 | 2019 | |
| Inspire Medical Systems, INC. | $24.14 | 2024 | Inspire |
| Travere Therapeutics, INC. | $20.23 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rayner Intraocular Lenses Limited | $14.30 | 2025 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Marano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.